Try our Advanced Search for more refined results
Genetic Technologies Limited v. Merial L.L.C.
Case Number:
1:12-cv-00396
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 30, 2014
BMS, Sanofi Get Gene Patent Partially Invalidated In IP Suit
A Delaware federal judge invalidated part of a DNA technology patent Genetic Technologies Ltd. accused Bristol-Myers Squibb Co. and a Sanofi-Aventis SA unit of infringing because it merely described a natural law, dooming the claim under the U.S. Supreme Court's landmark Mayo v. Prometheus decision.
-
May 02, 2012
Prometheus Dooms DNA Analysis Patent, Merial Claims
A patent held by Genetic Technologies Ltd. on a method of using DNA in genetic analysis should be invalidated in light of the U.S. Supreme Court's recent Prometheus ruling, Sanofi-Aventis SA's animal health unit Merial Ltd. said in a re-examination request filed Monday.